Cargando…
Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847534/ https://www.ncbi.nlm.nih.gov/pubmed/33517559 http://dx.doi.org/10.1007/s11739-021-02645-8 |
_version_ | 1783644941479575552 |
---|---|
author | Pardo-Cabello, Alfredo Jose Manzano-Gamero, Victoria Belda-Rustarazo, Susana Giner-Escobar, Pilar |
author_facet | Pardo-Cabello, Alfredo Jose Manzano-Gamero, Victoria Belda-Rustarazo, Susana Giner-Escobar, Pilar |
author_sort | Pardo-Cabello, Alfredo Jose |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7847534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-78475342021-02-01 Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment Pardo-Cabello, Alfredo Jose Manzano-Gamero, Victoria Belda-Rustarazo, Susana Giner-Escobar, Pilar Intern Emerg Med Ce - Letter to the Editor Springer International Publishing 2021-01-31 2021 /pmc/articles/PMC7847534/ /pubmed/33517559 http://dx.doi.org/10.1007/s11739-021-02645-8 Text en © Società Italiana di Medicina Interna (SIMI) 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Ce - Letter to the Editor Pardo-Cabello, Alfredo Jose Manzano-Gamero, Victoria Belda-Rustarazo, Susana Giner-Escobar, Pilar Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment |
title | Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment |
title_full | Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment |
title_fullStr | Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment |
title_full_unstemmed | Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment |
title_short | Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment |
title_sort | adverse drug reactions in sars-cov-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment |
topic | Ce - Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847534/ https://www.ncbi.nlm.nih.gov/pubmed/33517559 http://dx.doi.org/10.1007/s11739-021-02645-8 |
work_keys_str_mv | AT pardocabelloalfredojose adversedrugreactionsinsarscov2hospitalisedpatientsacaseserieswithafocusondrugdruginteractionscomment AT manzanogamerovictoria adversedrugreactionsinsarscov2hospitalisedpatientsacaseserieswithafocusondrugdruginteractionscomment AT beldarustarazosusana adversedrugreactionsinsarscov2hospitalisedpatientsacaseserieswithafocusondrugdruginteractionscomment AT ginerescobarpilar adversedrugreactionsinsarscov2hospitalisedpatientsacaseserieswithafocusondrugdruginteractionscomment |